Overuse of hospital antibiotics led to deadly superbug outbreak
Global epidemic of C. difficile that killed thousands were caused by two separate strains
Steve Connor is the Science Editor of The Independent and i. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; four times highly commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigations into the tobacco industry. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Sunday 09 December 2012
The widespread use of antibiotics in hospitals triggered the emergence of two resistant strains of the Clostridium superbug that has killed thousands of people worldwide over the past two decades, a study has shown.
A genetic analysis of about 300 samples of Clostridium difficile bacteria collected from around the world found that the global outbreaks were in fact caused by two different strains that had independently acquired resistance to an antibiotic widely used in hospitals.
Scientists traced the evolutionary trees of each strain of C. diff and found that both originated within a couple of years of each other, one in a hospital in Pittsburg, Pennsylvania, and the other in Montreal, Canada.
International travellers carried the Canadian strain to Britain and the rest of Europe, where it caused a notorious series of outbreaks in UK hospitals between 2003 and 2006, leading to hundreds of patients dying from bowel complications.
“We used advanced DNA sequencing to determine the evolutionary history of this epidemic and the subsequent pattern of global spread,” said Miao He, of the Wellcome Trust Sanger Institute in Cambridge, which carried out the genetic analysis.
“We found that this outbreak came from two separate epidemic strains or lineages of C. difficile, both emerging from North America over a very short period and rapidly spread between hospitals around the world.”
The study found that both strains of bacteria had undergone the same tiny mutation in a key gene that conferred resistance to the antibiotic fluoroquinolone.
Once resistance had evolved, the two strains quickly spread among hospital patients in North America and then Europe.
Trevor Lawley, the leader of the study at the Sanger Institute, said: “Until this research we didn’t realise that the same mutation had actually happened twice independently of one another. It shows that this is not a rare event and can happen again.
“There is a link between acquiring resistance and appearance of these mutations around the world, and the use of the antibiotics.”
The study, published in the journal Nature Genetics, said the evolution and persistence of fluoroquinolone-resistant strains of C. diff was likely to be the result of widespread use of this class of antibiotics in North America in the late 1990s and early 2000s.
Professor Brendan Wren, of the London School of Hygiene and Tropical Medicine, one of co-authors of the study, said: “Up until the early 2000s, fluoroquinolone was an effective treatment of C. diff infection. We’ve seen that since these strains acquired resistance to this frontline antibiotic, not only is it now virtually useless against this organism, but resistance seems to have been a major factor in the continued evolution and persistence of these strains in hospitals and clinical settings.”
The strain that evolved in the US, known as FQR1, later began to circulate in hospitals in Switzerland and South Korea. The strain that evolved Canada, called FQR2, spread far further, to Australia, France, Britain and other parts of Europe.
The scientists believe the outbreaks of FQR2 in British hospitals can be traced to three separate transmissions – from North America to hospitals in Exeter, Ayreshire and Birmingham. Another transmission, in Maidstone, came from Europe.
- 1 UK's biggest male rape charity Survivors UK has state funding slashed to zero despite 120% rise in men reporting sexual violence and seeking help
- 2 'Don't blame all men for rape' campaign backfires spectacularly
- 3 Isis burns woman alive for refusing to engage in 'extreme' sex act, UN says
- 4 Puerto Rico, island of lost dreams: People are leaving the debt-hit territory in droves as near neighbour Cuba's star rises
- 5 Charlie Charlie Challenge explained: not a Mexican demon being summoned — it's gravity
UK's biggest male rape charity Survivors UK has state funding slashed to zero despite 120% rise in men reporting sexual violence and seeking help
Iran launches anti-Isis cartoon competition 'to expose true nature of Islamic State'
Priest warns pupils the 'Charlie Charlie Challenge' is 'demonic activity'
Tinder and Grindr dating apps blamed for surge in cases of HIV, syphilis and other STDs
Fifa corruption arrests: Sepp Blatter 'quite relaxed' and confident he is 'not involved'
EU referendum: David Cameron's rules are a 'democratic disgrace', says French-born Scottish politician set to be denied a vote
The day that Britain resigned as a global power
SNP fury as HS2 finds 'no business case' for taking fast train service to Scotland
A nation of inequality: How the UK is failing to feed its most vulnerable people
Australian man punched in the face for defending Muslim women from abuse on train
EU referendum: David Cameron to deny EU migrants and under-18s the chance to vote
£20000 - £25000 per annum + OTE £45K YR1: SThree: At SThree, we like to be dif...
£30 - 40k + Benefits: Guru Careers: A Software / Web Developer (PHP / MYSQL) i...
£18 - 20k + Benefits: Guru Careers: An Account Executive is needed to join one...
£35 - 40k + Benefits: Guru Careers: A Software Developer / Software Engineer i...